Tech Company Financing Transactions
Imprint Labs Funding Round
Imprint Labs, operating out of New York, secured $15 million in investment from Convergent Research, Eric and private investors.
Transaction Overview
Company Name
Announced On
5/15/2025
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
private investors (Peter Reinhart)
private investors (Wendy Schmidt)
Proceeds Purpose
The company intends to use the funds to advance its work to decode the body's immune memory and uncover the causes of chronic diseases.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
180 Varick Street
New York, NY 10014
USA
New York, NY 10014
USA
Phone
Undisclosed
Website
Email Address
Overview
Imprint Labs is a forensic immunology Focused Research Organization (FRO) building experimental and machine learning tools to identify the hidden causes of - and cures for - chronic diseases. Not only an army, the immune system is also an archive: we aim to decode that archive at scale and reconstruct disease signatures from memory immune cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Beck Brachman
Browse more venture capital transactions:
Prev: 5/15/2025: Riverse venture capital transaction
Next: 5/15/2025: Repliers venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs